Cell Contact with Endothelial Cells Favors the In Vitro Maintenance of Human Chronic Myeloid Leukemia Stem and Progenitor Cells

Chronic Myeloid Leukemia (CML) originates in a leukemic stem cell that resides in the bone marrow microenvironment, where they coexist with cellular and non-cellular elements. The vascular microenvironment has been identified as an important element in CML development since an increase in the vascularization has been suggested to be related with poor prognosis; also, using murine models, it has been reported that bone marrow endothelium can regulate the quiescence and proliferation of leukemic stem and progenitor cells. This observation, however, has not been evaluated in primary human cells. In this report, we used a co-culture of primitive (progenitor and stem) CML cells with endothelial colony forming cells (ECFC) as an in vitro model to evaluate the effects of the vascular microenvironment in the leukemic hematopoiesis. Our results show that this interaction allows the in vitro maintenance of primitive CML cells through an inflammatory microenvironment able to regulate the proliferation of progenitor cells and the permanence in a quiescent state of leukemic stem cells.

[1]  H. Mayani,et al.  Understanding the hematopoietic microenvironment in chronic myeloid leukemia: A concise review. , 2021, Current research in translational medicine.

[2]  A. Chávez-González,et al.  Assessment of Cell Cycle in Primitive Chronic Myeloid Leukemia Cells by Flow Cytometry After Coculture with Endothelial Cells. , 2021, Methods in molecular biology.

[3]  Jianbo He,et al.  Mesenchymal Niche-Specific Expression of Cxcl12 Controls Quiescence of Treatment-Resistant Leukemia Stem Cells. , 2019, Cell stem cell.

[4]  Martin C. Müller,et al.  The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis , 2019, Haematologica.

[5]  A. Randi,et al.  Recent Advances in Endothelial Colony Forming Cells Toward Their Use in Clinical Translation , 2018, Front. Med..

[6]  Yate-Ching Yuan,et al.  Bone Marrow Niche Trafficking of miR-126 Controls Self-Renewal of Leukemia Stem Cells in Chronic Myelogenous Leukemia , 2018, Nature Medicine.

[7]  Atul Kumar,et al.  K562 chronic myeloid leukemia cells modify osteogenic differentiation and gene expression of bone marrow stromal cells , 2018, Journal of Cell Communication and Signaling.

[8]  T. Holyoake,et al.  Inhibition of interleukin-1 signaling enhances elimination of tyrosine kinase inhibitor-treated CML stem cells. , 2016, Blood.

[9]  H. Mayani,et al.  CDKIs p18INK4c and p57Kip2 are involved in quiescence of CML leukemic stem cells after treatment with TKI , 2016, Cell cycle.

[10]  A. Majluf-Cruz,et al.  Endothelial colony-forming cells: Biological and functional abnormalities in patients with recurrent, unprovoked venous thromboembolic disease. , 2016, Thrombosis research.

[11]  F. Syed,et al.  Potential Role of Notch Signalling in CD34+ Chronic Myeloid Leukaemia Cells: Cross-Talk between Notch and BCR-ABL , 2015, PloS one.

[12]  S. Raimondo,et al.  Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells. , 2014, Cancer letters.

[13]  G. Stefanzl,et al.  Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia. , 2014, Blood.

[14]  D. Campana,et al.  Microenvironmental protection of CML stem and progenitor cells from tyrosine kinase inhibitors through N-cadherin and Wnt-β-catenin signaling. , 2012, Blood.

[15]  K. Miyazono.  Tumour promoting functions of TGF-β in CML-initiating cells. , 2012, Journal of biochemistry.

[16]  J. Lévesque,et al.  Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance , 2012, Nature Medicine.

[17]  T. Holyoake,et al.  Altered microenvironmental regulation of leukemic and normal stem cells in chronic myelogenous leukemia. , 2012, Cancer cell.

[18]  J. Radich,et al.  IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. , 2011, Cancer cell.

[19]  S. Rafii,et al.  Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemia. , 2011, Cancer cell.

[20]  M. Ochi,et al.  Overexpression/enhanced kinase activity of BCR/ABL and altered expression of Notch1 induced acute leukemia in p210BCR/ABL transgenic mice , 2008, Oncogene.

[21]  D. Scadden,et al.  Tumor necrosis factor-alpha and endothelial cells modulate Notch signaling in the bone marrow microenvironment during inflammation. , 2008, Experimental hematology.

[22]  H. Mayani,et al.  Functional integrity in vitro of hematopoietic progenitor cells from patients with chronic myeloid leukemia that have achieved hematological remission after different therapeutic procedures. , 2006, Leukemia research.

[23]  K. Pollok,et al.  Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. , 2004, Blood.

[24]  K. Stamatopoulos,et al.  Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study , 2003, Leukemia.

[25]  C. Eaves,et al.  Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. , 1999, Blood.

[26]  A. Sarris,et al.  MCP-1, not MIP-1alpha, is the endogenous chemokine that cooperates with TGF-beta to inhibit the cycling of primitive normal but not leukemic (CML) progenitors in long-term human marrow cultures. , 1998, Blood.

[27]  C. Verfaillie,et al.  Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. , 1992, The Journal of clinical investigation.

[28]  M. Greaves,et al.  Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia , 1987, Nature.

[29]  L. Gaboury,et al.  Unregulated proliferation of primitive chronic myeloid leukemia progenitors in the presence of normal marrow adherent cells. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Rowley.  A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.